HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Müllberg, J. Articles by Rose-John, S. Search for Related Content PubMed PubMed Citation Articles by Müllberg, J. Articles by Rose-John, S.

IL-6 Receptor Independent Stimulation of Human gp130 by Viral IL-6¹

Jürgen Müllberg^2,*,3, Till Geib^2,*, Thomas Jostock^2,*, Susanne H. Hoischen^*, Petra Vollmer^*, Nicole Voltz^*, David Heinz^*, Peter R. Galle^*, Mariam Klouche and Stefan Rose-John^4,*

^* I. Medizinische Klinik, Abteilung Pathophysiologie, and Institut für Medizinische Microbiologie und Hygiene, Johannes Gutenberg-Universität Mainz, Mainz, Germany

The genome of human herpes virus 8, which is associated with Kaposi’s sarcoma, encodes proteins with similarities to cytokines and chemokines including a homologue of IL-6. Although the function of these viral proteins is unclear, they might have the potential to modulate the immune system. For viral IL-6 (vIL-6), it has been demonstrated that it stimulates IL-6-dependent cells, indicating that the IL-6R system is used. IL-6 binds to IL-6R, and the IL-6/IL-6R complex associates with gp130 which dimerizes and initiates intracellular signaling. Cells that only express gp130 but no IL-6R cannot be stimulated by IL-6 unless a soluble form of the IL-6R is present. This type of signaling has been shown for hematopoietic progenitor cells, endothelial cells, and smooth muscle cells. In this paper we show that purified recombinant vIL-6 binds to gp130 and stimulates primary human smooth muscle cells. IL-6R fails to bind vIL-6 and is not involved in its signaling. A Fc fusion protein of gp130 turned out to be a potent inhibitor of vIL-6. Our data demonstrate that vIL-6 is the first cytokine which directly binds and activates gp130. This property points to a possible role of this viral cytokine in the pathophysiology of human herpes virus 8.